Related Experiment Video
Updated: Mar 8, 2026
03:40
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
1.9K
On-Body Injector: An Administration Device for Pegfilgrastim.
Linda J Mahler1, Regina DiBlasi1, Anielka Perez1
1Stony Brook University Cancer Center.
Clinical Journal of Oncology Nursing
|January 21, 2017
Summary
The Onpro® on-body injector for pegfilgrastim (Neulasta®) simplifies chemotherapy support by preventing neutropenia. This study monitored its outpatient implementation, aiming to improve patient care and clinic workflow.
Area of Science:
- Oncology
- Pharmacology
- Health Services Research
Background:
- Granulocyte-colony-stimulating factors (G-CSFs) are crucial for preventing neutropenia in chemotherapy patients.
- Neulasta® (pegfilgrastim) is a common G-CSF requiring subcutaneous injection.
- The Onpro® on-body injector system for Neulasta® was introduced in March 2015.
Purpose of the Study:
- To monitor the implementation of the Neulasta® Onpro® on-body injector system.
- To assess the impact of the Onpro® system in an outpatient oncology setting.
Main Methods:
- Prospective monitoring of the Onpro® delivery system's integration into clinical workflow.
- Data collection on system usage, patient and staff experience, and operational efficiency.
Main Results:
- The Onpro® system was successfully implemented in the outpatient facility.
- Observed potential for improved patient convenience and enhanced clinic workflow.
Conclusions:
- The Onpro® on-body injector represents a significant advancement in G-CSF delivery.
- Further studies are warranted to fully evaluate long-term benefits and patient outcomes.
Related Concept Videos
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
70
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
70
01:29Drug Delivery: Parenteral Route
2.0K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.0K
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
67
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
67
01:27Insulin Formulations: Types and Delivery
904
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
904
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
357
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
357
01:21Intrauterine Drug Delivery Systems
69
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
69